Health Economics›Diffuse large B-cell lymphoma›Untreated

Untreated

Diffuse large B-cell lymphoma · 51 regimens

Cost estimates only — modelled on a typical patient (BSA 1.7 m², 70 kg, CrCl 90 mL/min) using the cheapest available formulary presentation. Excludes vial wastage, facility fees, supportive care, and infusion consumables. Not for billing, formulary decisions, or clinical use.

Filters

Y-axis

Cost vs Efficacy

No data points — cost or PFS missing for current selection.

Regimen	Biomarker	Cost/cycle ↓	Cycle	PFS ↕	OS ↕	Est. cycles	Course cost ↕	Evidence
VR-CHOP Variant #01	—	R 14 802	21d	—	—	—	—	—
R-CHMP Variant #01 Partial	—	R 12 473	21d	—	—	—	—	—
CCOP Variant #01	—	R 10 562	21d	—	—	—	—	—
VNCOP-B Variant #01	—	R 8 032	28d	—	—	—	—	—
PMitCEBO Variant #01	—	R 6 514	14d	—	—	—	—	—
DICEP Variant #01	—	R 5 437	—	—	—	—	—	—
ACVBP N/A - intrathecal component Partial	—	R 5 307	21d	—	—	—	—	1
PEN Variant #01	—	R 4 253	28d	—	—	—	—	—
CNOP Variant #01	—	R 3 876	28d	—	—	—	—	—
CNOP (Prednisolone) Variant #01	—	R 3 721	21d	—	—	—	—	—
CHOP Modified Variant #01	—	R 3 231	63d	—	—	—	—	—
ACEP Variant #01	—	R 2 784	14d	—	—	—	—	—
ACOMLA Variant #01	—	R 2 678	90d	—	—	—	—	—
P/DOCE Variant #01	—	R 2 594	21d	—	—	—	—	—
CEOP (Prednisolone) Variant #01	—	R 2 031	21d	—	—	—	—	—
CEOP Variant #01	—	R 1 941	21d	—	20.3 mo	—	—	—
CHOEP-14 Variant #01	—	R 1 887	14d	—	—	—	—	—
CHOEP-21 Variant #01	—	R 1 887	21d	—	—	—	—	—
F-MACHOP Variant #01	—	R 1 795	21d	—	—	—	—	—
CHOP-B Variant #02	—	R 1 744	28d	—	—	—	—	—
MACOP-B Variant #01	—	R 1 652	28d	—	—	—	—	—
HOP Variant #01	—	R 1 651	21d	—	—	—	—	—
DA-EPOCH Variant #01	—	R 1 522	21d	—	—	—	—	—
LD-ACOP-B Variant #01	—	R 1 521	42d	—	—	—	—	—
COMP Variant #01	—	R 1 519	37d	—	—	—	—	—
VABE Variant #01	—	R 1 401	14d	—	—	—	—	—
ProMACE-CytaBOM Variant #01	—	R 1 287	21d	—	—	—	—	—
PACEBOM Variant #01	—	R 1 183	14d	—	—	—	—	—
ProMACE-MOPP Variant #01 Partial	—	R 1 085	28d	—	—	—	—	—
VEPA Variant #01	—	R 1 082	21d	—	—	—	—	—
VACOP-B Variant #01	—	R 914	14d	—	—	—	—	—
CHOP (Prednisolone) Variant #01	—	R 878	21d	—	~11.8 mo	—	—	1
CHOP-14 Variant #01	—	R 872	14d	—	—	—	—	1
CHOP-BCG Variant #01	—	R 872	28d	—	—	—	—	—
CHOP Variant #13	—	R 859	21d	—	—	—	—	1
CAP-BOP Variant #01 Partial	—	R 856	28d	—	—	—	—	—
m-BACOD Variant #01	—	R 837	21d	—	~7.6 mo	—	—	2
COP-Bleo Variant #01	—	R 825	28d	—	—	—	—	—
CHVmP-VB Variant #01 Partial	—	R 799	21d	—	—	—	—	—
ABP Variant #01	—	R 752	21d	—	—	—	—	—
C-MOPP Variant #01 Partial	—	R 695	28d	—	—	—	—	—
CHVP Variant #01 Partial	—	R 635	28d	—	—	—	—	—
CVP Variant #01	—	R 585	21d	—	—	—	—	—
CHOP Modified (Prednisolone) Variant #01	—	R 522	21d	—	—	—	—	—
BCOP Variant #01 Partial	—	R 301	28d	—	—	—	—	—
Cyclophosphamide monotherapy N/A - secondary systemic drug	—	R 60	28d	—	~15.8 mo	—	—	1
CEEP N/A - intrathecal component	—	R 0	—	—	—	—	—	—
ACVBP (Methylprednisolone) N/A - intrathecal component	—	R 0	15d	—	—	—	—	—
VCAP N/A - intrathecal component	—	R 0	21d	—	—	—	—	—
ACE Partial	—	—	—	—	—	—	—	—
m-BNCOD Variant #01 Partial	—	—	—	—	—	—	—	—

51 of 51 regimens shown